stubborn op margin
conserv outlook could weigh
put beat though quarter pre-announc led
knees/mako neurotech trauma/extrem along broad strength
medsurg organ growth margin remain challeng
underli expans report
initi guidanc look conserv growth lack still
meaning om expans could take breather remain
anoth beat growth move anoth gear organ growth
adjust recal compar heavili adjust
last weather one less sell day
growth support strong print ahead street
divis medsurg print street ortho consensu
neuro/spin post street strength neuro
constant currenc off-set weak spine cc us
market describ still challeng knee growth particular notabl
us market mako distract competitor cementless knee creat
perfect storm initi guidanc organ growth fx
mako deliv mako instal increas global last includ
us last half instal base upgrad total knee
compani note placement competit account procedur
competit surgeon pace surgeon train remain
surgeon train total knee compani note account mako grow
rate without mako knee done last
tka done year use rough estim knees/q
us mako penetr competit surgeon convers
taken market sharenot bad first year launch mako prove
naysay us includ wrong far
new pt prior ep upper-end med-tech reflect
compani better growth risk includ price volum growth competit
continu page
ep exclud amort begin
pleas see analyst certif import disclosur inform inform regard statu non-u analyst page report
mid-single-digit growth ortho driven mostli volum
gain knee off-set modest price eros
low-teen growth med-surg physio-control
medic deal bake organ busi
steadi growth mako instal modest progress
tka convers
modest sale acceler novadaq
vexim deal
tuck-in deal exist vertic
target base ep
stronger-than-expect recon volum adopt
recoveri hospit capit spend drive upsid
estim medsurg
role model consist large-cap
medic devic drive upper-single-digit sale growth
mid-single-digit organ select
junctur stori share-tak
large-joint ortho market particularli knee hing
adopt robot platform mako continu
view time sacrific routin chang mako
potenti barrier widespread adopt
recogn syk impress fundament
stock trade upper-end large-cap med-tech
see valuat full
limit impact cjr entranc
higher accret physio control novadaq
vexim acquisit
signific devic asp headwind expect
procedur volum hospit capital-expenditure deterior
stem macroeconom factor
slower adopt mako due challeng valu
proposit exist orthoped surgeon
signific share gain expens exist
less accret acquisit
multipl lower ep yield
page
pleas see import disclosur inform page report
oper margin expans remain question report ep
growth oper margin full year op margin
well though commentari call suggest adjust
sever item pr acquisit om year would
similar correct wasnt given initi guidanc anoth
expans ep growth guid midpoint though
includ fx acquisit
adjust estim stay hold valuat ep stay
prior pt goe prior repres
ep sale growth remain best class question margin expans
relat ep growth well valuat keep us hold
page
pleas see import disclosur inform page report
